Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/2668
Title: Whole-Genome Sequences of Burkholderia pseudomallei Isolates Exhibiting Decreased Meropenem Susceptibility.
Publication Date: 2017-04-06
Authors: Price, Erin P
Smith, Melissa Laird
Paxinos, Ellen E
Tallon, Luke J
Sadzewicz, Lisa
Sengamalay, Naomi
Baird, Robert W
Currie, Bart J
Sarovich, Derek S
Affiliation: Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia eprice@usc.edu.au.. Centre for Animal Health Innovation, Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Sippy Downs, Queensland, Australia..
Pacific Biosciences, Menlo Park, California, USA..
Pacific Biosciences, Menlo Park, California, USA..
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA..
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA..
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA..
Department of Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia.. Pathology Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia..
Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.. Department of Infectious Diseases and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia..
Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.. Centre for Animal Health Innovation, Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Sippy Downs, Queensland, Australia..
Publication Date: 6-Apr-2017
Abstract: We report here paired isogenic Burkholderia pseudomallei genomes obtained from three patients receiving intravenous meropenem for melioidosis treatment, with post-meropenem isolates developing decreased susceptibility. Two genomes were finished, and four were drafted to improved high-quality standard. These genomes will be used to identify meropenem resistance mechanisms in B.¬†pseudomallei.
Journal title: Genome announcements
Citation: Genome announcements 2017-04-06; 5(14)
URI: https://hdl.handle.net/10137/2668
DOI: 10.1128/genomeA.00053-17
metadata.dc.identifier.orcid: http://orcid.org/0000-0002-1079-4882
http://orcid.org/0000-0002-6944-3980
PubMed: 28385830
ISSN: 2169-8287
Type: Journal Article
Appears in Collections:Upload

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.